First-in-Human, Healthy Volunteers Integrated Protocol of ETC-206, an Oral Mnk 1/2 Kinase Inhibitor Oncology Drug
10.1111/cts.12678
Saved in:
Main Authors: | Teneggi, V, Novotny-Diermayr, V, Lee, LH, Yasin, M, Yeo, P, Ethirajulu, K, Gan, SBH, Blanchard, SE, Nellore, R, Umrani, DN, Gomeni, R, Teck, DLW, Li, G, Lu, QS, Cao, Y, Matter, A |
---|---|
Other Authors: | DUKE-NUS MEDICAL SCHOOL |
Published: |
Wiley
2021
|
Online Access: | https://scholarbank.nus.edu.sg/handle/10635/187360 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Flowchart, etc.
by: Go, Myra M. de Leon
Published: (1986) -
MNK1 and MNK2 enforce expression of E2F1, FOXM1, and WEE1 to drive soft tissue sarcoma
by: Ke, Xin-Yu, et al.
Published: (2021) -
A Marketing plan for Cheesecake, Etc.
by: Gozo, Mary Angelette, et al.
Published: (2013) -
Probing the Binding Mechanism of Mnk Inhibitors by Docking and Molecular Dynamics Simulations
by: Kannan, Srinivasaraghavan, et al.
Published: (2016) -
ADDICTION OF SOFT-TISSUE SARCOMA CELLS TO MNK AND EIF4E
by: KE XINYU
Published: (2021)